Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 8/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.32 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.31 |
| ▸ | CKS1B | P61024 | 1/20 | 0.31 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19009799 | 0.89 | TOP1 (0.35) | TOP1TOP2AKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL19009816 | 0.86 | TOP2A (0.33) | TOP1TOP2AKCNN4KCNA5KDM4E | |
| SCHEMBL19009826 | 0.84 | TOP1 (0.42) | TOP1TOP2AKCNN4KCNA5DHODH | |
| SCHEMBL19009815 | 0.83 | CSNK2A2 (0.39) | TOP2ADHODH | |
| SCHEMBL19009800 | 0.81 | TOP1 (0.38) | TOP1DHODH | |
| SCHEMBL19051766 | 0.80 | TOP1 (0.40) | TOP1TOP2AKCNN4KCNA5KDM4E | |
| SCHEMBL19009837 | 0.80 | TOP2A (0.34) | TOP1TOP2AKCNN4KCNA5 | |
| SCHEMBL19009823 | 0.79 | CYP11B1 (0.35) | TOP1TOP2AKCNN4KCNA5ALDH1A1 | |
| SCHEMBL19051809 | 0.79 | TOP1 (0.35) | TOP1KCNN4KCNA5KDM4EALDH1A1 | |
| SCHEMBL19051799 | 0.78 | TOP1 (0.35) | TOP1TOP2AKCNN4KCNA5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | TOP1 898/4885PIK3CD 4428/4885TOP2A 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.